Abstract
Annexin A1 (AnxA1) is a potent anti-inflammatory protein that downregulates proinflammatory cytokine release. This study evaluated the role of AnxA1 in the regulation of NLRP3 inflammasome activation and lipid release by starch-elicited murine peritoneal macrophages. C57bl/6 wild-type (WT) and AnxA1-null (AnxA1-/-) mice received an intraperitoneal injection of 1.5% starch solution for macrophage recruitment. NLRP3 was activated by priming cells with lipopolysaccharide for 3 h, followed by nigericin (1 h) or ATP (30 min) incubation. As expected, nigericin and ATP administration decreased elicited peritoneal macrophage viability and induced IL-1β release, more pronounced in the AnxA1-/- cells than in the control peritoneal macrophages. In addition, nigericin-activated AnxA1-/- macrophages showed increased levels of NLRP3, while points of co-localization of the AnxA1 protein and NLRP3 inflammasome were detected in WT cells, as demonstrated by ultrastructural analysis. The lipidomic analysis showed a pronounced release of prostaglandins in nigericin-stimulated WT peritoneal macrophages, while ceramides were detected in AnxA1-/- cell supernatants. Different eicosanoid profiles were detected for both genotypes, and our results suggest that endogenous AnxA1 regulates the NLRP3-derived IL-1β and lipid mediator release in macrophages.
Highlights
Annexin A1 (AnxA1) is a 37-kDa protein that can mimic the anti-inflammatory action of glucocorticoids by inhibiting eicosanoid and phospholipase A2 synthesis, affecting components of inflammatory reaction and arachidonic acid release [1,2]
Considering that AnxA1 is a potent anti-inflammatory protein that down-regulates proinflammatory mediator release, phospholipase A2 and, the critical cascade pathways of eicosanoid production such as that of cyclooxygenase 2 (COX-2) [17,18], this study evaluated its role in regulating the NLRP3 inflammasome and lipid release by macrophages
We verified the endogenous effect of AnxA1 on the activation and regulation of NLRP3 inflammasome in macrophages
Summary
Annexin A1 (AnxA1) is a 37-kDa protein that can mimic the anti-inflammatory action of glucocorticoids by inhibiting eicosanoid and phospholipase A2 synthesis, affecting components of inflammatory reaction and arachidonic acid release [1,2]. The ability of AnxA1 to down-modulate cellular and molecular processes of inflammation contributes to tissue homeostasis and reprogramming of macrophages [3]. Cells 2020, 9, 926 understanding of the role of endogenous AnxA1 protein in leukocyte biology and the inflammatory process. Macrophages from AnxA1-/- mice demonstrate reduced ability to phagocytose non-opsonized zymosan particles [5], and show higher TLR4 mRNA expression and IL-1β production after lipopolysaccharide (LPS) stimulation than wild-type cells [6]. These data demonstrate that AnxA1 exerts a negative inflammatory response through its down-modulation effects on macrophage cells, which are important leukocytes in an innate response
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have